WallStreetZenWallStreetZen

NASDAQ: APLT
Applied Therapeutics Inc Stock Ownership - Who owns Applied Therapeutics?

Insider buying vs selling

Have Applied Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Riccardo PerfettiChief Medical Officer2023-01-116,053$0.91
$5.51kSell
Adam HansardChief Commercial Officer2023-01-114,495$0.91
$4.09kSell
Shoshana ShendelmanPresident and CEO2023-01-1115,870$0.91
$14.44kSell
Shoshana ShendelmanPresident and CEO2022-10-1450,000$0.65
$32.25kBuy
Shoshana ShendelmanPresident and CEO2022-10-1373,256$0.56
$40.88kBuy
Shoshana ShendelmanPresident and CEO2022-10-1238,153$0.52
$19.95kBuy
Joel S. MarcusDirector2022-09-144,125$1.05
$4.33kBuy
Joel S. MarcusDirector2022-09-147,389$1.05
$7.76kBuy
Joel S. MarcusDirector2022-09-1410,230$1.05
$10.74kBuy
Joel S. MarcusDirector2022-09-1416,500$1.05
$17.33kBuy

1 of 2

APLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLT insiders and whales buy or sell their stock.

APLT Shareholders

What type of owners hold Applied Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Franklin Resources Inc8.26%4,775,484$6.45MInstitution
Alexandria Real Estate Equities Inc7.87%4,555,077$6.15MInsider
Shoshana Shendelman7.04%4,075,101$5.50MInsider
Knoll Capital Management LLC5.96%3,450,000$4.66MInstitution
Fmr LLC5.14%2,972,371$4.01MInstitution
Simplify Asset Management Inc4.12%2,382,621$3.22MInstitution
Vanguard Group Inc1.48%855,155$1.15MInstitution
Alyeska Investment Group LP1.38%799,102$1.08MInstitution
Rock Springs Capital Management LP1.35%780,791$1.05MInstitution
Point72 Asset Management LP1.24%719,938$971.92kInstitution

1 of 3

APLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLT33.32%18.21%Net Buying
XLO49.39%50.61%
MTNB12.25%13.75%
CLGN13.60%0.00%
VTVT3.41%57.36%Net Buying

Applied Therapeutics Stock Ownership FAQ

Who owns Applied Therapeutics?

Applied Therapeutics (NASDAQ: APLT) is owned by 33.32% institutional shareholders, 18.21% Applied Therapeutics insiders, and 48.46% retail investors. Alexandria Real Estate Equities Inc is the largest individual Applied Therapeutics shareholder, owning 4.56M shares representing 7.87% of the company. Alexandria Real Estate Equities Inc's Applied Therapeutics shares are currently valued at $6.65M.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.